The Abstract Submission for the European NF Conference 2026 is now closed!
We thank you all for your numerous submissions!
The abstracts are now in the review process.
The Notification of Abstract Acceptance / Rejection will be sent to each submitter via direct email on September 9, 2026.
We will not accept any late breaking abstracts, thanks for your understanding.
If you would like to amend the presenting author (must be one of the current author block), the submitting author can contact us via eunf2026vienna@aimgroup.eu by stating paper number, title, and new presenting author.
If you would like to withdraw your abstract, the submitting author can contact us via eunf2026vienna@aimgroup.eu. Depending on the date of withdrawal, we will try to remove it from all publications.
Abstract embargo policy: We will publish all accepted abstract contents not earlier than one week prior to the conference start online and in our digital abstract book.
Guidelines & Documentation
You can find the Abstract Topics, Abstract Submission Guidelines and Abstracts Terms & Conditions hereunder.
Scientific Programme Committee
Clinical Science
-
Assoc. Prof. Dr. Amedeo Azizi
(AT) -
Dr. Laura Fertitta
(FR)
Basic Science
-
Ao. Prof. Dr. Katharina Wimmer
(AT) -
Eduard Serra, PhD
(ES)
Patient Advocate
-
Ing. Claas Röhl
(AT) -
Gilles Atlan
(UK / IL)
Join the 2026 European Neurofibromatosis Conference in Vienna, 12–14 November. Explore advances in NF1, Schwannomatosis, and patient-centred research at Hyatt Regency Vienna (previously Andaz Vienna Am Belvedere).